In vitro biocompatibility of titanium after plasma surface alloying with boron

Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:1240-7. doi: 10.1016/j.msec.2016.08.006. Epub 2016 Aug 6.

Abstract

Recently, the effect of different sizes of precursor powders during surface plasma alloying modification on the properties of titanium surface was studied. In this work we show in vitro test results of the titanium (α-Ti) after plasma surface alloying with boron (B). Ti-B nanopowders with 2 and 10wt% B were deposited onto microcrystalline Ti substrate. The in vitro cytocompatibility of these biomaterials was evaluated and compared with a conventional microcrystalline Ti. During the studies, established cell line of human gingival fibroblasts and osteoblasts were cultured in the presence of tested materials, and its survival rate and proliferation activity were examined. For this purpose, MTT assay, flow cytometric and fluorescent microscopic evaluation were made. Biocompatibility tests carried out indicate that the Ti after plasma surface alloying with B could be a possible candidate for dental implants and other medicinal applications. Plasma alloying is a promising method for improving the properties of titanium, thus increasing the field of its applications.

Keywords: Boron; Cell proliferation; Cell viability; Microplasma alloying; Nanoprecursors; Titanium.

MeSH terms

  • Alloys / pharmacology*
  • Biocompatible Materials / pharmacology*
  • Boron / pharmacology*
  • Cell Cycle / drug effects
  • Cell Death / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Crystallization
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fluorescence
  • Humans
  • Materials Testing / methods*
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Plasma Gases / pharmacology*
  • Surface Properties
  • Titanium / pharmacology*
  • X-Ray Diffraction

Substances

  • Alloys
  • Biocompatible Materials
  • Plasma Gases
  • Titanium
  • Boron